Ossiam Biomarin Pharmaceutical Inc Transaction History

Ossiam

$8.56 Billion
Q2 2025

A detailed history of Ossiam transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Ossiam holds 208 shares of BMRN stock, worth $10,797. This represents 0.0% of its overall portfolio holdings.

Number of Shares

208

Previous 208 -0.0%

Holding current value

$10,797

Previous $14,000 21.43%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	SELL	$61.25 - $72.83 $16,415 - $19,518	-268 Reduced 56.3%	208 $14,000
Q4 2024 Feb 13, 2025	SELL	$61.93 - $70.49 $146,712 - $166,990	-2,369 Reduced 83.27%	476 $31,000
Q3 2024 Nov 13, 2024	SELL	$69.02 - $93.84 $8,351 - $11,354	-121 Reduced 4.08%	2,845 $199,000
Q2 2024 Aug 13, 2024	BUY	$74.43 - $92.22 $372 - $461	5 Added 0.17%	2,966 $244,000
Q1 2024 May 13, 2024	SELL	$83.81 - $99.0 $142,812 - $168,696	-1,704 Reduced 36.53%	2,961 $258,000
Q4 2023 Feb 13, 2024	BUY	$76.22 - $98.51 $148,324 - $191,700	1,946 Added 71.57%	4,665 $449,000
Q3 2023 Nov 14, 2023	SELL	$85.07 - $94.48 $4,423 - $4,912	-52 Reduced 1.88%	2,719 $240,000
Q2 2023 Aug 11, 2023	BUY	$86.68 - $100.3 $111,557 - $129,086	1,287 Added 86.73%	2,771 $240,000
Q1 2023 May 12, 2023	SELL	$87.74 - $117.27 $491,080 - $656,360	-5,597 Reduced 79.04%	1,484 $144,000
Q4 2022 Feb 13, 2023	BUY	$80.93 - $108.63 $212,036 - $284,610	2,620 Added 58.73%	7,081 $732,000
Q3 2022 Nov 14, 2022	SELL	$82.16 - $96.94 $106,972 - $126,215	-1,302 Reduced 22.59%	4,461 $378,000
Q2 2022 Aug 12, 2022	BUY	$71.48 - $86.85 $111,437 - $135,399	1,559 Added 37.08%	5,763 $478,000
Q1 2022 May 13, 2022	BUY	$74.28 - $92.69 $138,606 - $172,959	1,866 Added 79.81%	4,204 $324,000
Q4 2021 Feb 14, 2022	SELL	$71.72 - $91.47 $51,566 - $65,766	-719 Reduced 23.52%	2,338 $207,000
Q2 2021 Aug 13, 2021	BUY	$75.51 - $84.79 $119,909 - $134,646	1,588 Added 108.1%	3,057 $235,000
Q1 2021 May 17, 2021	BUY	$74.73 - $90.69 $54,253 - $65,840	726 Added 97.71%	1,469 $111,000
Q4 2020 Feb 12, 2021	BUY	$72.61 - $90.2 $45,308 - $56,284	624 Added 524.37%	743 $65,000
Q3 2020 Nov 12, 2020	SELL	$71.87 - $131.03 $144,889 - $264,156	-2,016 Reduced 94.43%	119 $9,000
Q2 2020 Aug 13, 2020	SELL	$79.55 - $124.22 $755,168 - $1.18 Million	-9,493 Reduced 81.64%	2,135 $263,000
Q1 2020 May 14, 2020	BUY	$71.37 - $96.85 $697,998 - $947,193	9,780 Added 529.22%	11,628 $983,000
Q4 2019 Feb 14, 2020	BUY	$64.27 - $86.37 $104,503 - $140,437	1,626 Added 732.43%	1,848 $156,000
Q3 2019 Nov 13, 2019	SELL	$67.4 - $85.11 $37,474 - $47,321	-556 Reduced 71.47%	222 $15,000
Q2 2019 Aug 13, 2019	BUY	$80.35 - $93.9 $62,512 - $73,054	778 New	778 $67,000

Others Institutions Holding BMRN

# of Institutions

693

Shares Held

187M

Call Options Held

1.31M

Put Options Held

1.1M

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $9.65B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ossiam, based on Form 13F filings with the SEC.

News

Stay updated on Ossiam with notifications on news.

Account